comprehensive -WSS

comprehensive

author：entertainment 2025-09-03 03:39:32 - browse：38

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Intercept Pharmaceuticals sells itself for less than $1 billion

focus

WSS

Ionis has late

Has Bernie Sanders reached the limit of his pharma bullying effort?

AltruBio raises $225 million to develop ulcerative colitis drug

Most antidepressants don't work on kids, teens, study finds

Listen: Who gets the credit for GLP

Paxlovid should be available without a positive Covid test

hotspot

comprehensive

hotspot

Alkermes shareholders re

Welsh Carson private equity firm escapes from FTC antitrust case

Peter Hotez and the public health issue of online harassment

Empower primary care with adequate payments and technology

Drug repurposing or repositioning? The language matters

Deliver public health messages at the right time

BioMarin wins approval for gene therapy to treat hemophilia A

Brain MRIs reveal impact of 'toxic stress' on Black children

Dobbs anniversary: the lost opportunity of abortion as health care

Brain MRIs reveal impact of 'toxic stress' on Black children

focus

Brain MRIs reveal impact of 'toxic stress' on Black children

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Brain technologies pose threats that are all too real, experts warn

Medicare drug price negotiation program allowed for now

As health system earnings go up, health insurance stocks go down

Crowdfunding for medical bills sidesteps core problem, author says

leisure time

focus

leisure time

focus